April 15, 2019, 11:28 am

Celgene shareholders OK sale to Bristol-Myers


 15-04-2019 11:28 AM

Summit-based biopharmaceutical company Celgene Corp. announced Friday that its shareholders have approved its sale to Bristol-Myers Squibb. The deal, valued at $74 billion when it was announced in January, was approved by stockholders representing more than 70% of the shares outstanding,...

Posted in:
Return On Information New Jersey
Return On Information New Jersey

This article was posted online by Return On Information New Jersey. Spot On New Jersey collects excepts of news articles from this news source and add these in the 'New Jersey Business'-category. For mor einformation about Spot On New Jersey, you can check the About Us-page.

This story was posted in the category: